Is Benzisothiazolinone safe in cosmetics?
Benzisothiazolinone has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Also known as: Caswell No. 079A, Caswell No. 513A, EINECS 220-120-9, EPA Pesticide Chemical Code 098901, UNII-HRA0F1A4R3 (+5 more)
INCI: BENZISOTHIAZOLINONE
Benzisothiazolinone (CAS 2634-33-5) is a cosmetic preservative functioning as Preservative; biocide. NOAEL 69 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max Permitted in rinse-off cosmetics; restricted or banned in leave-on products. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 2634-33-5 →
Benzisothiazolinone is classified GHS Danger (H302, H315, H317, H318, H400, H410, H411) in the chemicals database but is restricted in EU cosmetics at max Permitted in rinse-off cosmetics; restricted or banned in leave-on products.
Source: Cosmetics: ingredients.eu_status/eu_max; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Benzisothiazolinone.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Benzisothiazolinone. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =15 mg/kg/day | oral | rat | repeated dose toxicity | SCCNFP_vision_codex |
| NOAEL | =15 mg/kg/day | oral | rat | repeated dose toxicity | SCCNFP_vision_codex |
| NOAEL | =15 mg/kg/day | oral | rat | repeated dose toxicity | SCCNFP_vision_codex |
| NOAEL | =15 mg/kg/day | oral | rat | repeated dose toxicity | SCCNFP_vision_codex |
| NOAEL | =0.018 mg/kg bw/d | oral | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.018 mg/kg bw/d | oral | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.018 mg/kg bw/d | oral | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.018 mg/kg bw/d | oral | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =8.42 mg/kg bw/day | oral | rat | repeated dose toxicity | SCCS_vision_codex |
| NOAEL | =8.42 mg/kg bw/day | oral | rat | repeated dose toxicity | SCCS_vision_codex |
Pre-calculated NOAEL → SED → MoS audit trail for Benzisothiazolinone across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Benzisothiazolinone based on clinical patch test studies and IFRA standards.
Source: NACDG 2021-22; ESSCA 2019/20
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LD50 | >2000 mg/kg | Rat | dermal | - | ECHA IUCLID |
| LD50 | >2000 mg/kg | Rat | dermal | - | ECHA IUCLID |
| LD50 | =454 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | =670 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | =490 mg/kg | Rat | oral | - | ECHA IUCLID |
| LOAEL | =20 mg/kg-day | Dog | oral | subchronic | ECHA IUCLID |
| NOAEL | =150 mg/kg-day | Rat | oral | short-term | ECHA IUCLID |
| NOAEL | =5 mg/kg-day | Dog | oral | subchronic | ECHA IUCLID |
| NOAEL | =69 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =112 mg/kg-day | Rat | oral | - | ECHA IUCLID |
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: ATP21
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: Botham et al. (1991) | Gerberick et al. (2005); DPRA: Nukada et al. 2013 [DOI:10.1016/j.tiv.2012.11.006] | Gerberick et al. 2007 [DOI:10.1093/toxsci/kfh213]; KS: Emter et al. 2010 [DOI:10.1016/j.taap.2010.03.009]; hCLAT: Ashikaga et al. 2010 [DOI:10.1177/026119291003800403]
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
Source list: II
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| Thyroid hormone levels (T3/T4 ↓); tshβ↑, deio2↓ | Thyroid axis (TR / deiodinase / TSH feedback) | EC50/IC50: LOEC = 30 µg/L (zebrafish T3/T4 decrease); LOEC: 30 µg/L; NOEC: not established mixed | thyroid disruptor |
| ERα / AR binding or transactivation | ERα / AR | EC50/IC50: No published EC50 for ER/AR; SCCS opinion focused on skin sensitization; LOEC: not reported; NOEC: not reported mixed | not assessed in published ER/AR assays (data gap) |
| AhR transactivation | AhR | EC50/IC50: No AhR data published for BIT at sub-cytotoxic concentrations; LOEC: not established; NOEC: N/A mixed | not active (data gap; BIT thyroid data stronger) |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured | 61.9% | - | - | SCCS/0099 |
| measured | 42.05% | - | - | SCCS/0099 |
3 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Benzisothiazolinone.
Public NOAEL study rows linked to Benzisothiazolinone by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg bw/d, mg/kg bw
| Absorption % | Method | Vehicle |
|---|---|---|
| 61.9% | - | - |
| 42.05% | - | - |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Benzisothiazolinone has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Benzisothiazolinone EU regulatory status: restricted. Maximum allowed concentration: Permitted in rinse-off cosmetics; restricted or banned in leave-on products. This is based on EU Regulation 1223/2009 and its amendments.
Benzisothiazolinone functions as: Preservative; biocide. It is classified as a Preservative in our database. CAS number: 2634-33-5.
The NOAEL (No Observed Adverse Effect Level) for Benzisothiazolinone is =15 mg/kg/day based on a repeated dose toxicity study via oral route in rat. A total of 10 study endpoints are available. Source: SCCNFP_vision_codex.
Benzisothiazolinone also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Benzisothiazolinone is classified GHS Danger (H302, H315, H317, H318, H400, H410, H411) in the chemicals database but is restricted in EU cosmetics at max Permitted in rinse-off cosmetics; restricted or banned in leave-on products.
Check Benzisothiazolinone compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Benzisothiazolinone in your formulation.